Presbyopia implant trial looks good for Refocus
This article was originally published in Clinica
Executive Summary
Eye disorders medical device firm Refocus Group has reported that its scleral implants have yielded promising preliminary results in a phase II US trial that is testing the devices as a treatment for presbyopia.